Boltwood Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$7.32M |
| 2 |
Microchip Technology
MCHP
|
+$1.04M |
| 3 |
STJ
St Jude Medical
STJ
|
+$968K |
| 4 |
Salesforce
CRM
|
+$591K |
| 5 |
CELG
Celgene Corp
CELG
|
+$509K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Prologis
PLD
|
+$20.6M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$17.6M |
| 3 |
Expeditors International
EXPD
|
+$16.9M |
| 4 |
Martin Marietta Materials
MLM
|
+$13.5M |
| 5 |
Wells Fargo
WFC
|
+$13.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.36% |
| 2 | Financials | 11.59% |
| 3 | Technology | 9.9% |
| 4 | Energy | 8.56% |
| 5 | Consumer Staples | 7.38% |
Similar funds
Boltwood Capital Management's Q2 2015 Portfolio in Review
As of Q2 2015, Boltwood Capital Management held 96 positions worth $102M, down 70% from $341M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Boltwood Capital Management withdrew a net $238M in Q2 2015, closing 16 positions and reducing 55 holdings. Its most notable exit was Prologis, an estimated $20.6M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 10% a quarter earlier, followed by Financials and Technology.
Against the trend, Boltwood Capital Management opened a new position in Microchip Technology worth $1.02M.
- Boltwood Capital Management's largest Q2 2015 buy was Microchip Technology: 42,860 shares worth $1.02M.
- Boltwood Capital Management added most to Pfizer in Q2 2015, an estimated $7.32M increase.
- Boltwood Capital Management's biggest Q2 2015 reduction was Alphabet (Google) Class C, cutting an estimated $17.6M.
- Boltwood Capital Management fully exited Prologis in Q2 2015, selling an estimated $20.6M.
- Boltwood Capital Management's ten largest holdings make up 39% of its $102M portfolio in Q2 2015.
- Boltwood Capital Management opened 5 new positions and closed 16 in Q2 2015.
- Boltwood Capital Management's portfolio value fell 70% quarter-over-quarter to $102M.
Based on Boltwood Capital Management's 13F filing for Q2 2015, filed 24 Jul 2015.